Company Quick10K Filing
United Guardian
Closing Price ($) Shares Out (MM) Market Cap ($MM)
$0.00 5 $86
10-K 2020-03-26 Annual: 2019-12-31
10-Q 2019-11-12 Quarter: 2019-09-30
10-Q 2019-08-12 Quarter: 2019-06-30
10-Q 2019-05-09 Quarter: 2019-03-31
10-K 2019-03-21 Annual: 2018-12-31
10-Q 2018-11-09 Quarter: 2018-09-30
10-Q 2018-08-08 Quarter: 2018-06-30
10-Q 2018-05-11 Quarter: 2018-03-31
10-K 2018-03-22 Annual: 2017-12-31
10-Q 2017-11-09 Quarter: 2017-09-30
10-Q 2017-08-09 Quarter: 2017-06-30
10-Q 2017-05-11 Quarter: 2017-03-31
10-K 2017-03-23 Annual: 2016-12-31
10-Q 2016-11-09 Quarter: 2016-09-30
10-Q 2016-08-09 Quarter: 2016-06-30
10-Q 2016-05-13 Quarter: 2016-03-31
10-K 2016-03-24 Annual: 2015-12-31
10-Q 2015-11-12 Quarter: 2015-09-30
10-Q 2015-08-11 Quarter: 2015-06-30
10-Q 2015-05-12 Quarter: 2015-03-31
10-K 2015-03-26 Annual: 2014-12-31
10-Q 2014-11-12 Quarter: 2014-09-30
10-Q 2014-08-08 Quarter: 2014-06-30
10-Q 2014-05-09 Quarter: 2014-03-31
10-K 2014-03-24 Annual: 2013-12-31
10-Q 2013-11-12 Quarter: 2013-09-30
10-Q 2013-08-08 Quarter: 2013-06-30
10-Q 2013-05-10 Quarter: 2013-03-31
10-K 2013-03-21 Annual: 2012-12-31
10-Q 2012-11-13 Quarter: 2012-09-30
10-Q 2012-08-09 Quarter: 2012-06-30
10-Q 2012-05-09 Quarter: 2012-03-31
10-K 2012-03-26 Annual: 2011-12-31
10-Q 2011-11-09 Quarter: 2011-09-30
10-Q 2011-08-08 Quarter: 2011-06-30
10-Q 2011-05-10 Quarter: 2011-03-31
10-K 2011-03-25 Annual: 2010-12-31
10-Q 2010-11-12 Quarter: 2010-09-30
10-Q 2010-08-10 Quarter: 2010-06-30
10-Q 2010-05-07 Quarter: 2010-03-31
10-K 2010-03-25 Annual: 2009-12-31
8-K 2020-03-19 Earnings, Exhibits
8-K 2019-11-22 Regulation FD, Exhibits
8-K 2019-11-08 Earnings, Exhibits
8-K 2019-08-09 Earnings, Exhibits
8-K 2019-05-15 Shareholder Vote, Regulation FD, Exhibits
8-K 2019-05-09 Earnings, Exhibits
8-K 2019-03-21 Accountant, Exhibits
8-K 2019-03-21 Earnings, Exhibits
8-K 2018-11-29 Regulation FD, Exhibits
8-K 2018-11-08 Earnings, Exhibits
8-K 2018-08-08 Earnings, Exhibits
8-K 2018-05-18 Regulation FD, Exhibits
8-K 2018-05-16 Shareholder Vote
8-K 2018-05-10 Earnings, Exhibits
8-K 2018-03-22 Earnings, Exhibits

United Guardian Financials

UG Metrics, Comps, Filings

Annual | Quarterly

Business

United-Guardian, Inc. ("United", "Registrant", or "Company") is a Delaware corporation that, through its Guardian Laboratories Division ("Guardian"), manufactures and markets cosmetic ingredients, personal care products, pharmaceuticals, medical lubricants, health care products, and specialty industrial products. It also conducts research and product development, primarily related to the development of new and unique cosmetic and personal care products. The Company's research and development department also modifies, refines, and expands the uses for existing products, with the goal of further developing the market for the Company's products.

United's predecessor, United International Research, Inc. ("UIR"), was founded and incorporated in New York in 1942 by Dr. Alfred R. Globus, United's Chairman and Director of Research until his death on April 9, 2009. On February 10, 1982, a merger took place between UIR and Guardian Chemical Corp. ("GCC"), an affiliate of UIR, whereby GCC was merged into UIR and the name was changed to United-Guardian, Inc., a New York corporation. On September 14, 1987, United-Guardian, Inc. (New York) was merged with and into a newly-formed Delaware corporation by the same name, United-Guardian, Inc., for the purpose of changing the domicile of the Company to Delaware.

The Company has a broad range of products, some of which are currently marketed and some of which are still in the research and development stage. Of the products being actively marketed, the two largest product lines are the LUBRAJEL® line of cosmetic ingredients and medical lubricants, which accounted for approximately 67% of the Company's sales in 2018, and RENACIDIN® IRRIGATION SOLUTION ("RENACIDIN"), a pharmaceutical product that accounted for approximately 27% of the Company's sales in 2018. All references in this Annual Report to "sales" or "Sales" shall mean Gross Sales.


Valuation ($MM)

Market Cap, Enterprise Value

Balance Sheet ($MM)

Assets, Stockholders' Equity

Income Statement ($MM Annual)

Revenue, Gross Profit, Net Income

Cash Flow ($MM Annual)

Operating, Investing, Financing

Comps ($'000 TTM) Market Cap Gross Margin EV/EBITDA Ret on Assets Assets Liabilities Revenue G Profit Net Income EBITDA EV
Procter & Gamble (PG) 278,659,335 49% 32.4 4% 115,095,000 67,516,000 67,684,000 32,916,000 4,633,000 9,249,000 299,798,335
Unilever (UN) 92,149,467 0% 59,456,000 47,164,000 0 0 0 0 89,975,467
Estee Lauder (EL) 67,431,320 77% 21.5 15% 13,156,000 8,745,000 14,863,000 11,490,000 1,921,000 3,138,000 67,340,320
Colgate Palmolive (CL) 63,762,157 59% 18.3 18% 13,151,000 13,161,000 15,406,000 9,117,000 2,423,000 3,801,000 69,540,157
Unilever (UL) 61,757,691 0% 59,456,000 47,164,000 0 0 0 0 59,583,691
Ecolab (ECL) 55,006,650 41% 20.2 7% 20,827,600 12,558,200 14,772,500 6,050,600 1,511,100 3,021,700 60,908,050
Church & Dwight (CHD) 19,235,524 44% 20.6 9% 6,662,600 4,057,800 4,243,200 1,886,700 603,300 1,030,000 21,245,624
Coty (COTY) 9,878,280 62% -5.8 -21% 17,665,400 12,620,200 8,648,500 5,342,000 -3,769,500 -2,960,900 17,243,680
Stepan (SCL) 2,111,741 18% 9.7 7% 1,528,968 671,310 1,936,829 340,705 104,316 212,500 2,069,112
Inter Parfums (IPAR) 2,017,216 63% 17.8 9% 815,192 356,203 698,925 443,095 73,051 107,368 1,905,809
Avon Products (AVP) 1,715,698 56% 11.1 -1% 2,971,200 3,423,800 5,187,600 2,928,500 -14,900 223,200 2,484,098
Edgewell Personal Care (EPC) 1,440,376 45% -10.4 -11% 3,452,300 2,097,800 2,150,400 968,300 -374,200 -230,000 2,386,376
Revlon (REV) 1,025,877 56% 25.1 -7% 3,201,000 4,260,100 2,520,400 1,423,900 -219,000 163,000 4,095,177
e.l.f. Beauty (ELF) 715,006 61% 19.4 -0% 435,981 213,973 268,365 163,570 -621 41,350 800,452
Level Brands (LEVB) 125,573 61% -1.8 -62% 100,909 75,763 16,420 10,020 -62,624 -64,661 113,940
United Guardian (UG) 85,684 57% 15.7 34% 12,503 1,803 12,852 7,389 4,201 5,406 84,773
S&W Seed (SANW) 85,525 65% -28.7 -6% 146,364 46,366 62,877 40,708 -9,305 -3,323 95,365
CCA Industries (CAW) 16,521 61% 49.9 -23% 14,155 5,852 16,607 10,070 -3,322 340 16,991
cbdMD (YCBD)

Balance Sheet ($'000)2011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-31
Cash1,0911,7481,6342,0231,080424725550
Accounts Receivable1,6531,0181,7911,5939351,5981,9051,673
Inventory1,4671,2431,6111,2371,2941,2561,3411,482
PP&E1,2451,2367,0601,2081,0961,091943828
Assets15,25613,85915,65115,93915,68815,11912,85312,545
Accounts Payable4001513861419783354187
Long-Term Debt
Liabilities1,1421,0211,4151,2021,1061,2981,4561,620
Stockholders' Equity14,11412,83814,23614,73714,58213,82011,39710,925
Income Statement ($'000)2011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-31
Revenue14,33913,82615,41713,45014,00610,77712,96813,769
Cost of Revenue5,6505,2195,6115,3185,2024,8835,3015,667
Gross Profit8,6888,6079,8068,1328,8045,8947,6678,102
R&D693717730648652646400
SG&A
Tax2,1552,0962,6051,8672,1251,0501,7061,114
Net Income4,7174,8315,9034,0504,6072,5813,8444,352
Cash Flow ($'000)2011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-31
Cash Operating4,4375,3815,8054,4815,2002,2903,9924,950
Cash Investing-1,1841,528-1,461-414-1,6744902,815-309
Cash Financing-3,677-6,251-4,459-3,677-4,469-3,437-6,507-4,816